The Advanced Research Projects Agency for Health has selected UpDoc as the lead performer in its ADVOCATE program, awarding up to $9.2 million to develop an autonomous clinical AI system for cardiovascular care. The initiative involves major technology partners including Microsoft, OpenAI, and NVIDIA, aiming to create a system capable of managing heart failure under FDA authorization through rigorous validation and real-world deployment. This represents a structured federal effort to bridge the gap between prototype agentic AI and regulated clinical use, involving health systems like Cleveland Clinic and UCSF Health. For financial institutions, this signals a potential near-term revenue stream for participating cloud and chip vendors while highlighting the regulatory complexity that may slow broader enterprise adoption of autonomous agents.
309 other tracked developments touching the same claims.